跳至主要内容
临床试验/NCT06575439
NCT06575439招募中不适用

An Observational Study of Predictors and Outcomes of Lung Cancer in Never-smokers in the UK

University College London Hospitals1 个研究点 分布在 1 个国家目标入组 225 人开始时间: 2024年9月17日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
225
试验地点
1
主要终点
Demographics, comorbidities and environmental exposures of participants

研究概览

简要总结

The goal of this observational study is to improve the early detection of lung cancer in adults who have smoked less than 100 tobacco cigarettes ("never-smokers") in the United Kingdom. The main questions it aims to answer are:

  • To describe characteristics such as demographics, co-morbidities and environmental exposures
  • To describe participant pathways including presentation mode and symptoms to understand if earlier diagnosis would be possible
  • To describe participant outcomes such as cancer stage, treatment and mortality
  • To quantitatively or qualitatively measure modifiable and non-modifiable factors that may be associated with LCINS including environmental measures, blood tests and genomic data.

Participants will currently have no change to their usual care.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All adult participants from age of 18 who are diagnosed or treated with primary lung cancer through radiology or histology at any participating study site

排除标准

  • Participants who have ever smoked cigarettes or tobacco will be excluded; this is defined as:
  • More than 100 cigarettes or 75g tobacco in their lifetime
  • Those who have received a prescription for nicotine replacement therapy
  • For prospective participants, those who cannot consent will be excluded

结局指标

主要结局

Demographics, comorbidities and environmental exposures of participants

时间窗: Comorbidities and environmental exposures at diagnosis (approximately up to 156 weeks prior to diagnosis)

From review of electronic health records

Participant pathways including presentation mode and symptoms

时间窗: Presentation mode and symptoms at time of diagnosis (approximately up to 52 weeks prior to diagnosis)

From review of electronic health records

次要结局

  • Participant outcomes such as cancer stage, treatment, mortality(Cancer stage at time of diagnosis, treatment and mortality through study completion (likely 5 years))
  • Measurement of modifiable and non-modifiable factors associated with LCINS(Through study completion (likely 5 years))

研究者

发起方
University College London Hospitals
申办方类型
Other
责任方
Principal Investigator
主要研究者

Neal Navani

Professor of Respiratory Medicine

University College, London

研究点 (1)

Loading locations...

相似试验